KaliVir Immunotherapeutics, Inc.
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2022
KaliVir closes Series A financing
KaliVir Immunotherapeutics announced the closing of its Series A financing, with proceeds intended to support internal programs and advance its lead product candidate into development.